Asia-Pacific Pharmaceutical Packaging Market – Industry Trends and Forecast to 2030

Asia-Pacific Pharmaceutical Packaging Market Analysis and Size

Pharmaceutical packaging has been about since the discovery of the pharmaceutical industries. Primarily, pharmaceutical packaging was not available in an extensive range but the increasing specifications and growing demand made it possible. Modern-day healthcare professionals and consumers demand convenient packaging that is easy to dispose of. This growing requirement, in turn, propel the producers towards the expansion of innovative packaging. Moreover, “oral drug delivery packaging” is expected to be the fastest growing product type segment during the forecast period owing to their convenience, safety, ease of consumption and cost-effectiveness.

Data Bridge Market Research analyses that the pharmaceutical packaging market is expected to reach USD 69.36 billion by 2030, which is USD 24.92 billion in 2022, registering a CAGR of 13.65% during the forecast period of 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.     

Asia-Pacific Pharmaceutical Packaging Market Scope and Segmentation

Market Definition

Packaging is an important part for the pharmaceutical product. There are several types of packaging for pharmaceutical products. Manufacturers are mainly used to create durable pharmaceutical casing for packaging, shielding layers for packaging products such as closures and lids, and many more. Packaging products are mainly used to store liquid, solid and semisolid formulations, such as syrups, tablets, capsules and topical drug formulations.

Asia-Pacific Pharmaceutical Packaging Market Dynamics

Drivers

• Rising demand for plastics and polymers  based pharmaceutical packaging

There are various types of plastic resins options available in the market including polyethylene, polypropylene, polyethylene terephthalate, polyvinyl chloride and bioplastic which are extensively used for manufacturing syringes, pouches, sachets, cartridges, pharmaceutical vials, bottles, closures,  tubes, and blister packs. Polypropylene accounted for the largest share in the plastic and polymers material segment because it provides a combination of beneficial properties, such as electrical, mechanical, physical and thermal characteristics. Thus, the rising demand for plastics and polymers based pharmaceutical packaging is expected to drive the growth rate of the market.

• Increasing  demand of child resistant packaging

Plastic bottles are widely used for the pharmaceutical packaging which comprise child-resistant closure and caps. According to the United States Food and Drug Administration, pharmaceutical plastic packaging manufacturers also have to use the label to highlight “child-resistant packaging” on the pharmaceutical product to describe the customer. Pouches and Ziplock bags are also gaining considerable drive in the pharmaceutical packaging market because it needs a skill to slide the zipper and access the product, which aids to keeping the product away from the children. Therefore, increasing demand of child resistant packaging is anticipated to drive market growth rate, Opportunities

• Surging innovations in pharmaceutical packaging

The companies of pharmaceutical packaging are focusing on innovations to decrease the usage of plastics and carbon emissions which has associated with blister packaging. For instance, a global shift has been witnessed in the pharmaceutical companies in the European Union and other regulated markets for generics towards eco-friendly and sustainable primary packaging, resulting in the increasing preference toward the polylactic acid (PLA) based packaging among pharmaceutical manufacturers. Moreover, according to the data which has published by Honeywell International Inc. in January 2022, polylactic acid (PLA) consumes 65% less energy during the production. As a result of all these factor increase the demand for the eco-friendly and sustainable primary packaging which will create numerous opportunities factor for the growth of the market during the forecast period

Restraints/ Challenges

• Stringent regulations for using plastic packaging

Government imposed strict rules for using plastic based packaging in pharmaceutical packaging which may act as major restraint for some extent. It has adversely impacted the profit of the manufacturers. On the other hand, using biodegradable raw materials is very costly than non-biodegradable which increases the overall production costs. Therefore, growing cost pressure will also restrain the growth of the market.

This pharmaceutical packaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growth  application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pharmaceutical packaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

COVID-19 Impact on Pharmaceutical Packaging Market

The outbreak of COVID-19 pandemic had a diverse effect on the healthcare sector. The pharmaceutical industry was adversely affected by the lack of preparedness, supply chain disruptions, shortage of manpower, infrastructure and shortage of essential drugs. As a response, many countries started reshoring pharmaceutical manufacturing or strengthening their operations in the pharmaceutical sector. Therefore, the pandemic highlighted the significance of localization in pharmaceutical packaging.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Recent Development

• In 2021, Klöckner Pentaplast Group (U.K.), a leading manufacturer of high barrier protective packaging solutions, launched kpNext. It is the first innovation in market in recyclable polyethylene terephthalate (PET) blister films
• In 2021, Keystone Folding Box Co. (U.S.) reported augmented demand for paperboard based blister packs for the pharmaceutical packaging. This rise in demand was triggered by the introduction of environmental sustainability law in India and augmented demand for the child-resistant pharmaceuticals packaging in the U.S.
• In 2021, Amcor Plc launched customer trials for a new mono-material and recyclable polyethylene blister pack named AmSky. This brand reduces the usage of polyvinyl chloride which is making recycling possible.

Asia-Pacific Pharmaceutical Packaging Market Scope

The pharmaceutical packaging market is segmented on the basis of type, raw material, drug delivery mode, purchase organization and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Plastic Bottles
• Blister Packs
• Labels and Accessories
• Caps and Closures
• Medical Specialty Bags
• Pre-Filled Syringes
• Temperature-Controlled Packaging
• Pouches and Strip Packs
• Ampoules
• Vials
• Pre-Filled Inhalers
• Medication Tubes
• Jars and Canisters
• Cartridges
• Others

Raw Material

• Plastics and Polymers
• Paper and Paperboards
• Glass
• Metals
• Others

Drug Delivery Mode

• Oral Drug Delivery Packaging
• Pulmonary Drug Delivery Packaging
• Transdermal Drug Delivery Packaging
• Injectable Packaging
• Nasal Drug Delivery Packaging
• Ocular Drug Delivery Packaging
• IV Drugs Delivery Packaging
• Others

 Purchase Organization

• Manufacturer
• Packaging Companies
• Government Agencies

Application

• Drug Delivery
• Veterinary Vaccines

Pharmaceutical Packaging Market Regional Analysis/Insights

The pharmaceutical packaging market is analyzed and market size insights and trends are provided by country, type, raw material, drug delivery mode, purchase organization and application as referenced above.

The countries covered in the pharmaceutical packaging market report Japan, China, India, South Korea, Australia and New Zealand, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific.

China dominates the pharmaceutical packaging market in terms of market share and revenue due to growing government initiatives, such as Healthy China 2020. Furthermore, increasing burgeoning aging population and contract-manufacturing activities will further enhance the market growth in.this region.

Asia-Pacific is expected to be the fastest developing region during the forecast period of 2023-2030 owing to the substantial entrance of market players in this region.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Pharmaceutical Packaging Market Share Analysis

The pharmaceutical packaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pharmaceutical packaging market.

Some of the major players operating in the pharmaceutical packaging market are:

• Gerresheimer AG (Germany)
• SCHOTT AG (Germany)
• Alpha Packaging (U.S.)
• Klöckner Pentaplast (Germany)
• Amcor Plc (Switzerland)
• Berry Global, Inc (U.S.)
• BD (U.S.)
• Parekhplast India Ltd (India)
• West Pharmaceutical Services, Inc (U.S.)
• Wipak Group (Finland)
• Mondi (U.K.)
• Sealed Air (U.S.)
• Constantia Flexible (Austria)
• Clondalkin Group (Netherlands)
• Huhtamaki (Finland)
• Transcontinental Inc. (Canada)
• Crown Holdings, Inc (U.S.)
• Westrock Company (U.S.)
• Drug plastics Group (U.S.)
• SGD Pharma (India)

SKU-17243